The aim of this paper is to provide an accurate overview regarding the current recommended approach for antihypertensive treatment. The importance of DNA sequencing in understanding the complex implication of genetics in hypertension could represent an important step in understanding antihypertensive treatment as well as in developing new medical strategies. Despite a pool of data from studies regarding cardiovascular risk factors emphasizing a worse prognosis for female patients rather than male patients, there are also results indicating that women are more likely to be predisposed to the use of antihypertensive medication and less likely to develop uncontrolled hypertension. Moreover, lower systolic blood pressure values are associated with increased cardiovascular risk in women compared to men. The prevalence, awareness and, most importantly, treatment of hypertension is variable in male and female patients, since the mechanisms responsible for this pathology may be different and closely related to gender factors such as the renin–angiotensin system, sympathetic nervous activity, endothelin-1, sex hormones, aldosterone, and the immune system. Thus, gender-related antihypertensive treatment individualization may be a valuable tool in improving female patients’ prognosis.
CITATION STYLE
Luca, C. T., Crisan, S., Cozma, D., Negru, A., Lazar, M. A., Vacarescu, C., … Iurciuc, S. (2021). Arterial hypertension: Individual therapeutic approaches—from dna sequencing to gender differentiation and new therapeutic targets. Pharmaceutics. MDPI AG. https://doi.org/10.3390/pharmaceutics13060856
Mendeley helps you to discover research relevant for your work.